HB 1611-FN – AS INTRODUCED

2014 SESSION

14-2071

01/04

HOUSE BILL 1611-FN

AN ACT adding certain products to the controlled drug act.

SPONSORS: Rep. Emerson, Ches 11; Rep. Andrews-Ahearn, Rock 37; Rep. DiMartino, Belk 2; Rep. J. Johnson, Ches 12; Rep. Chase, Ches 8; Sen. Carson, Dist 14; Sen. Larsen, Dist 15; Sen. Gilmour, Dist 12; Sen. Lasky, Dist 13

COMMITTEE: Criminal Justice and Public Safety

ANALYSIS

This bill prohibits the possession or use of synthetic cannabinoid agonists or piperazines and methylenedioxypyrovalerone or bath salts by placing them on schedule I of the controlled drug schedules.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Explanation: Matter added to current law appears in bold italics.

Matter removed from current law appears [in brackets and struckthrough.]

Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.

14-2071

01/04

STATE OF NEW HAMPSHIRE

In the Year of Our Lord Two Thousand Fourteen

AN ACT adding certain products to the controlled drug act.

Be it Enacted by the Senate and House of Representatives in General Court convened:

1 New Paragraph; Controlled Drug Act; Definition Added. Amend RSA 318-B:1 by inserting after paragraph III the following new paragraph:

III-a. “Bath salts” means any synthetic chemical compound that contains methylenedioxypyrovalerone, mephedrone, pyrovalerone, and methylone otherwise known as MDPV.

2 New Paragraph; Controlled Drug Act; Definition Added. Amend RSA 318-B:1 by inserting after paragraph XXXI the following new paragraph:

XXXI-a. “Synthetic cannabinoid agonists or piperazines” means any chemical compound that contains Benzylpiperazine; Trifluoromethylphenylpiperazine; 1,1-Dimethylheptyl-ll-hydroxytetra-hydrocannabinol; 1-Butyl-3-(1-naphthoyl)indole; 1-Pentyl-3-(1-naphthoyl)indole; dexanabinol; or 2-[(1R,3S)-3-hydroxycyclohexyl] -5-(2-methyloctan -2-yl)phenol). The term shall not include synthetic cannabinoids that require a prescription, are approved by the United States Food and Drug Administration, and are dispensed in accordance with state and federal law.

3 New Section; Synthetic Cannabinoid Agonists or Piperazines; Methylenedioxypyrovalerone or Bath Salts. Amend RSA 318-B by inserting after section 1-c the following new section:

318-B:1-d Synthetic Cannabinoid Agonists or Piperazines and Methylenedioxypyrovalerone or Bath Salts.

I. The general court intends that the provisions of paragraph II of this section shall remain in effect until such time as synthetic cannabinoid agonists or piperazines and methylenedioxypyrovalerone or bath salts are scheduled by the commissioner of the department of health and human services in accordance with RSA 318-B.

II. Notwithstanding the provisions of RSA 318-B:1-a, relative to scheduling by rulemaking of the commissioner of the department of health and human services, synthetic cannabinoid agonists or piperazines and methylenedioxypyrovalerone or bath salts shall be placed on schedule I of controlled drugs.

4 Effective Date. This act shall take effect upon its passage.

LBAO

14-2071

12/17/13

HB 1611-FN - FISCAL NOTE

AN ACT adding certain products to the controlled drug act.

FISCAL IMPACT:

METHODOLOGY: